betaxolol has been researched along with Postoperative Complications in 3 studies
Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a double masked randomised clinical trial, 38 eyes from 38 pseudophakic patients over 21 years of age who had significant posterior capsule opacification after phacoemulsification were randomly assigned to receive either betaxolol 0." | 5.51 | The prophylactic effect of betaxolol 0.5% versus brimonidine 0.2% on IOP elevation after Nd:YAG laser posterior capsulotomy. ( Elmi Sadr, N; Paknazar, F; Saber, E, 2022) |
| "Betaxolol is a new beta-adrenergic receptor blocker that preferentially blocks beta 1 receptors." | 5.27 | Aphakic cystoid macular edema secondary to betaxolol therapy. ( Hesse, RJ; Swan, JL, 1988) |
| "Betaxolol is a new beta-adrenergic receptor blocker that preferentially blocks beta 1 receptors." | 1.27 | Aphakic cystoid macular edema secondary to betaxolol therapy. ( Hesse, RJ; Swan, JL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Elmi Sadr, N | 1 |
| Saber, E | 1 |
| Paknazar, F | 1 |
| Zheng, K | 1 |
| Brock-Utne, JG | 1 |
| Hesse, RJ | 1 |
| Swan, JL | 1 |
1 trial available for betaxolol and Postoperative Complications
| Article | Year |
|---|---|
The prophylactic effect of betaxolol 0.5% versus brimonidine 0.2% on IOP elevation after Nd:YAG laser posterior capsulotomy.
Topics: Betaxolol; Brimonidine Tartrate; Capsule Opacification; Glaucoma; Humans; Intraocular Pressure; Lens | 2022 |
2 other studies available for betaxolol and Postoperative Complications
| Article | Year |
|---|---|
Can preoperative betaxolol eye drops reduce the incidence of postoperative visual loss (POVL)?
Topics: Adrenergic beta-Antagonists; Betaxolol; Humans; Intraocular Pressure; Middle Aged; Ophthalmic Soluti | 2014 |
Aphakic cystoid macular edema secondary to betaxolol therapy.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Cataract Extraction; Female; Glauco | 1988 |